{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T16:13:30Z","timestamp":1788970410115,"version":"build-2803163510"},"reference-count":20,"publisher":"Oxford University Press (OUP)","issue":"9","license":[{"start":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T00:00:00Z","timestamp":1780358400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,9,9]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>This study aimed to quantify the long-term risk of second primary lung cancer (SPLC) following adjuvant breast radiotherapy (RT) and to evaluate its clinical significance in determining the appropriate duration of lung cancer screening among breast cancer survivors.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A total of 370\u2009782 female patients who underwent loco-regional breast adjuvant RT after breast cancer surgery were included for analysis using the US SEER-9 Plus database from 1975 to 2018. Additionally, survival analyses were conducted to compare patients with SPLC following adjuvant breast RT with those with only first primary lung cancer (PLC). PLC patients, defined as those diagnosed with only primary lung cancer and no other malignancies throughout their lifetime, were derived from the same SEER database for the survival analysis, not from external published data.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>SPLC diagnosed at least 5\u00a0years after breast cancer was observed in 5632 patients (1.52%), comprising 2630 patients (1.55%) in the RT cohort and 3002 patients (1.49%) in the non-radiotherapy cohort. RT was associated with an increased risk of SPLC (adjusted hazard ratio [HR], 1.28; 95% CI, 1.22\u20131.35; P\u00a0&amp;lt;\u00a0.001). The median overall survival time for SPLC after breast RT was longer than that for primary lung cancer (18.0\u00a0months [95% CI, 17.0\u201320.0] vs. 14.0\u00a0months [95% CI, 13.0\u201316.0], P\u00a0=\u00a0.008). The 10-year overall survival rate of the SPLC patients after breast RT was significantly higher than that of primary lung cancer (14.3% [95% CI, 12.6\u201316.2] vs. 13.1% [95% CI, 11.6\u201314.8], P\u00a0=\u00a0.008), with an HR of 0.92 (95% CI, 0.86\u20130.98, P\u00a0=\u00a0.008).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Interpretation<\/jats:title>\n                    <jats:p>RT for loco-regional breast cancer was associated with an increased risk of developing SPLC. Given this increased risk, routine screening for SPLC should be considered for this population, particularly within 5\u201315\u00a0years following breast cancer diagnosis.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/jjco\/hyag089","type":"journal-article","created":{"date-parts":[[2026,5,17]],"date-time":"2026-05-17T11:33:21Z","timestamp":1779017601000},"page":"1080-1087","source":"Crossref","is-referenced-by-count":0,"title":["Impact of adjuvant breast radiotherapy on the risk and the survival of second primary lung cancer: a large population-based study"],"prefix":"10.1093","volume":"56","author":[{"given":"Nan-Nan","family":"Ji","sequence":"first","affiliation":[{"name":"Department of Radiation Oncology, Cancer Treatment Center, The Second Affiliated Hospital of Hainan Medical University , 368 Yehai Road, Haikou 570311 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue-Yan","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Clinical Oncology, Shengjing Hospital of China Medical University , 39 Huaxiang Road, Tiexi District, Shenyang 110022 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shao-Qing","family":"Xiao","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Cancer Treatment Center, The Second Affiliated Hospital of Hainan Medical University , 368 Yehai Road, Haikou 570311 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Cancer Treatment Center, The Second Affiliated Hospital of Hainan Medical University , 368 Yehai Road, Haikou 570311 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Li","family":"Su","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Cancer Treatment Center, The Second Affiliated Hospital of Hainan Medical University , 368 Yehai Road, Haikou 570311 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun-Nv","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Cancer Treatment Center, The Second Affiliated Hospital of Hainan Medical University , 368 Yehai Road, Haikou 570311 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Shao","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Cancer Treatment Center, The Second Affiliated Hospital of Hainan Medical University , 368 Yehai Road, Haikou 570311 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu-Ning","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Cancer Treatment Center, The Second Affiliated Hospital of Hainan Medical University , 368 Yehai Road, Haikou 570311 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-8723-7652","authenticated-orcid":false,"given":"Yue-Can","family":"Zeng","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Cancer Treatment Center, The Second Affiliated Hospital of Hainan Medical University , 368 Yehai Road, Haikou 570311 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,6,2]]},"reference":[{"key":"2026090910434564700_ref1","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1056\/NEJMoa2207586","article-title":"Breast-conserving surgery with or without irradiation in early breast cancer","volume":"388","author":"Kunkler","year":"2023","journal-title":"N Engl J Med"},{"key":"2026090910434564700_ref2","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1016\/S0140-6736(11)61629-2","article-title":"Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10 801 women in 17 randomised trials","volume":"378","author":"Darby","year":"2011","journal-title":"Lancet."},{"key":"2026090910434564700_ref3","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1002\/cac2.12025","article-title":"Cancer burden of major cancers in China: a need for sustainable actions","volume":"40","author":"Cao","year":"2020","journal-title":"Cancer Commun (London, England)"},{"key":"2026090910434564700_ref4","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21708","article-title":"Cancer statistics, 2022","volume":"72","author":"Siegel","year":"2022","journal-title":"CA Cancer J Clin"},{"key":"2026090910434564700_ref5","doi-asserted-by":"publisher","first-page":"2893","DOI":"10.1200\/JCO.2017.72.4203","article-title":"Risk stratification for second primary lung cancer","volume":"35","author":"Han","year":"2017","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"key":"2026090910434564700_ref6","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1038\/s41523-021-00280-2","article-title":"Risk of primary lung cancer after adjuvant radiotherapy in breast cancer-a large population-based study","volume":"7","author":"Wennstig","year":"2021","journal-title":"NPJ Breast Cancer"},{"key":"2026090910434564700_ref7","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/j.ijrobp.2006.12.011","article-title":"Risk of second malignancies after adjuvant radiotherapy for breast cancer: a large-scale, single-institution review","volume":"68","author":"Kirova","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2026090910434564700_ref8","doi-asserted-by":"publisher","first-page":"1893","DOI":"10.1016\/j.jtho.2021.07.001","article-title":"Risk and influencing factors for subsequent primary lung cancer after treatment of breast cancer: a systematic review and two meta-analyses based on four million cases","volume":"16","author":"Wang","year":"2021","journal-title":"J Thorac Oncol"},{"key":"2026090910434564700_ref9","doi-asserted-by":"publisher","first-page":"427","DOI":"10.3389\/fonc.2018.00427","article-title":"Second primary lung cancer after breast cancer: a population-based study of 6,269 women","volume":"8","author":"Wang","year":"2018","journal-title":"Front Oncol"},{"key":"2026090910434564700_ref10","doi-asserted-by":"publisher","first-page":"107295","DOI":"10.1016\/j.lungcan.2023.107295","article-title":"Accelerated subsequent lung cancer after post-operative radiotherapy for breast cancer","volume":"182","author":"Basse","year":"2023","journal-title":"Lung Cancer"},{"key":"2026090910434564700_ref11","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1007\/s12282-021-01318-w","article-title":"Risk of primary lung cancer after breast cancer radiotherapy: a systematic review and meta-analysis","volume":"29","author":"Zareie","year":"2022","journal-title":"Breast Cancer-Tokyo"},{"key":"2026090910434564700_ref12","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1016\/j.jtho.2017.01.021","article-title":"Radiation therapy for invasive breast cancer increases the risk of second primary lung cancer: a nationwide population-based cohort analysis","volume":"12","author":"Huang","year":"2017","journal-title":"J Thorac Oncol"},{"key":"2026090910434564700_ref13","doi-asserted-by":"publisher","first-page":"e2031661","DOI":"10.1001\/jamanetworkopen.2020.31661","article-title":"Association of radiotherapy for rectal cancer and second gynecological malignant neoplasms","volume":"4","author":"Guan","year":"2021","journal-title":"JAMA Netw Open"},{"key":"2026090910434564700_ref14","doi-asserted-by":"publisher","first-page":"205031212110177","DOI":"10.1177\/20503121211017757","article-title":"Epidemiology and clinicopathological features of lung cancer in patients with prior history of breast cancer","volume":"9","author":"Wang","year":"2021","journal-title":"SAGE Open Med"},{"key":"2026090910434564700_ref15","doi-asserted-by":"publisher","DOI":"10.1177\/1559325818796331","article-title":"Health impacts of low-dose ionizing radiation: current scientific debates and regulatory issues","volume":"16","author":"Vaiserman","year":"2018","journal-title":"Dose-Response"},{"key":"2026090910434564700_ref16","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.lungcan.2019.09.001","article-title":"Let us not underestimate the long-term risk of SPLC after surgical resection of NSCLC","volume":"137","author":"Leroy","year":"2019","journal-title":"Lung Cancer (Amsterdam, Netherlands)"},{"key":"2026090910434564700_ref17","doi-asserted-by":"publisher","first-page":"8662","DOI":"10.1002\/cam4.4351","article-title":"Nonmetastatic breast cancer patients subsequently developing second primary malignancy: a population-based study","volume":"10","author":"Bao","year":"2021","journal-title":"Cancer Med"},{"key":"2026090910434564700_ref18","doi-asserted-by":"publisher","first-page":"14790","DOI":"10.1038\/s41598-021-94357-4","article-title":"Survival analysis of patients with primary breast duct carcinoma and lung adenocarcinoma: a population-based study from SEER","volume":"11","author":"Lv","year":"2021","journal-title":"Sci Rep"},{"key":"2026090910434564700_ref19","doi-asserted-by":"publisher","first-page":"5309","DOI":"10.2147\/CMAR.S312419","article-title":"Prognostic characteristics of operated breast cancer patients with second primary lung cancer: a retrospective study","volume":"13","author":"Wang","year":"2021","journal-title":"Cancer Manag Res"},{"key":"2026090910434564700_ref20","doi-asserted-by":"publisher","DOI":"10.1093\/bjsopen\/zrab115","article-title":"Primary lung cancer in women after previous breast cancer","volume":"5","author":"Nobel","year":"2021","journal-title":"BJS Open"}],"container-title":["Japanese Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jjco\/article-pdf\/56\/9\/1080\/68454921\/hyag089.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jjco\/article-pdf\/56\/9\/1080\/68454921\/hyag089.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T15:31:55Z","timestamp":1788967915000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jjco\/article\/56\/9\/1080\/8700085"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,2]]},"references-count":20,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,6,2]]},"published-print":{"date-parts":[[2026,9,9]]}},"URL":"https:\/\/doi.org\/10.1093\/jjco\/hyag089","relation":{},"ISSN":["1465-3621"],"issn-type":[{"value":"1465-3621","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,9]]},"published":{"date-parts":[[2026,6,2]]}}}